Review article: acute severe ulcerative colitis - evidence-based consensus statements

Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection

(2016) Mette Julsgaard et al.   GASTROENTEROLOGY

Ulcerative Colitis Is Associated With an Increased Risk of Venous Thromboembolism in the Postoperative Period

(2015) Matthew Z. Wilson et al.   ANNALS OF SURGERY

An Accelerated Infliximab Induction Regimen Reduces the Need for Early Colectomy in Patients With Acute Severe Ulcerative Colitis

(2015) David J. Gibson et al.   Clinical Gastroenterology and Hepatology

Association Between the Ulcerative Colitis Endoscopic Index of Severity (UCEIS) and Outcomes in Acute Severe Ulcerative Colitis

(2015) C. Corte et al.   Journal of Crohns & Colitis

865 PIANO: A 1000 Patient Prospective Registry of Pregnancy Outcomes in Women With IBD Exposed to Immunomodulators and Biologic Therapy

(2015) Uma Mahadevan et al.   GASTROENTEROLOGY

157 Fecal Loss of Infliximab As a Cause of Lack of Response in Severe Inflammatory Bowel Disease

(2015) Johannan F Brandse et al.   GASTROENTEROLOGY

Corticosteroid use and risk of orofacial clefts

(2014) Hildur Skuladottir et al.   BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY

960 Exposure to Anti-TNFα Therapy in the Third Trimester of Pregnancy Is Not Associated With Increased Adverse Outcomes: Results From the PIANO Registry

(2014) Uma Mahadevan et al.   GASTROENTEROLOGY

786 The Pharmacokinetics of Infliximab Induction Therapy in Patients With Moderate to Severe Ulcerative Colitis

(2014) Johannan F. Brandse et al.   GASTROENTEROLOGY

Allopurinol enhanced thiopurine treatment for inflammatory bowel disease: safety considerations and guidelines for use

(2014) M. X. Min et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

P377 Pregnancy outcome and counselling of anti-TNF-alpha treated IBD women: an ongoing international multicentre study

(2014) M. Julsgaard et al.   Journal of Crohns & Colitis

Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

(2014) J.F. Rahier et al.   Journal of Crohns & Colitis

Allopurinol

(2014) Faith D. Ihekweazu et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Randomised controlled trial. Comparison Of iNfliximab and ciclosporin in STeroid Resistant Ulcerative Colitis: Trial design and protocol (CONSTRUCT)

(2014) Anne C Seagrove et al.   BMJ Open

Outcomes of salvage therapy for steroid-refractory acute severe ulcerative colitis: ciclosporin vs. infliximab

(2013) A. Croft et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Outcomes of rescue therapy in acute severe ulcerative colitis: data from the United Kingdom inflammatory bowel disease audit

(2013) R. W. Lynch et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Practice Parameters for the Surgical Treatment of Ulcerative Colitis

(2013) Howard Ross et al.   DISEASES OF THE COLON & RECTUM

Ciclosporin Use During Pregnancy

(2013) Karolina Paziana et al.   DRUG SAFETY

Occupational health and safety of anti-tumour necrosis factor alpha monoclonal antibodies with casual exposure

(2013) Jeff Chang et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Reliability and Initial Validation of the Ulcerative Colitis Endoscopic Index of Severity

(2013) Simon P.L. Travis et al.   GASTROENTEROLOGY

Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis

(2013) William J. Sandborn et al.   GASTROENTEROLOGY

Combination Therapy With Infliximab and Azathioprine Is Superior to Monotherapy With Either Agent in Ulcerative Colitis

(2013) Remo Panaccione et al.   GASTROENTEROLOGY

Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel disease

(2013) Bindia Jharap et al.   GUT

Increased Risk of Pneumocystis Jiroveci Pneumonia Among Patients with Inflammatory Bowel Disease

(2013) Millie D. Long et al.   INFLAMMATORY BOWEL DISEASES

Therapeutic Drug Monitoring of Infliximab and Mucosal Healing in Inflammatory Bowel Disease

(2013) Stephane Paul et al.   INFLAMMATORY BOWEL DISEASES

The Impact of Surgeon Volume on Postoperative Outcomes After Surgery for Crohnʼs Disease

(2013) Geoffrey C. Nguyen et al.   INFLAMMATORY BOWEL DISEASES

The effect of allopurinol and low-dose thiopurine combination therapy on the activity of three pivotal thiopurine metabolizing enzymes: Results from a prospective pharmacological study

(2013) M.L. Seinen et al.   Journal of Crohns & Colitis

Mucosal healing with oral tacrolimus is associated with favorable medium- and long-term prognosis in steroid-refractory/dependent ulcerative colitis patients

(2013) Jun Miyoshi et al.   Journal of Crohns & Colitis

N-ECCO Consensus statements on the European nursing roles in caring for patients with Crohn's disease or ulcerative colitis

(2013) M. O'Connor et al.   Journal of Crohns & Colitis

Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis

(2013) Brian G. Feagan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Total abdominal colectomy for severe ulcerative colitis: does the laparoscopic approach really have benefit?

(2013) Jinyu Gu et al.   SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES

Efficacy of infliximab in acute severe ulcerative colitis: A single-centre experience

(2013) Stephen J Halpin   WORLD JOURNAL OF GASTROENTEROLOGY

Review article: a decision-making algorithm for the management of pregnancy in the inflammatory bowel disease patient

(2012) F. M. Habal et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Short-term efficacy of tacrolimus in steroid-refractory ulcerative colitis - experience in 130 patients

(2012) K. J. Schmidt et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Prevention of VTE in Nonsurgical Patients

(2012) Susan R. Kahn et al.   CHEST

The Impact of Preoperative Stoma Site Marking on the Incidence of Complications, Quality of Life, and Patient’s Independence

(2012) Benjamin Person et al.   DISEASES OF THE COLON & RECTUM

Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease

(2012) Harry Sokol et al.   INFLAMMATORY BOWEL DISEASES

Safety and Effectiveness of Long-term Allopurinol–Thiopurine Maintenance Treatment in Inflammatory Bowel Disease

(2012) Frank Hoentjen et al.   INFLAMMATORY BOWEL DISEASES

OP10 Importance of trough levels and antibodies on the long-term efficacy of infliximab therapy in ulcerative colitis

(2012) M.T. Arias et al.   Journal of Crohns & Colitis

Cyclosporine or infliximab as rescue therapy in severe refractory ulcerative colitis: Early and long-term data from a retrospective observational study

(2012) Filippo Mocciaro et al.   Journal of Crohns & Colitis

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis

(2012) Axel Dignass et al.   Journal of Crohns & Colitis

Optimising outcome on thiopurines in inflammatory bowel disease by co-prescription of allopurinol

(2012) Melissa A. Smith et al.   Journal of Crohns & Colitis

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management

(2012) Axel Dignass et al.   Journal of Crohns & Colitis

Lymphoma and other lymphoproliferative disorders in inflammatory bowel disease: A review

(2012) Kavitha Subramaniam et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Extended thromboprophylaxis for medically ill patients with decreased mobility: does it improve outcomes?

(2012) A. SHARMA et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial

(2012) David Laharie et al.   LANCET

Thiopurine methyl-transferase activity and azathioprine metabolite concentrations do not predict clinical outcome in thiopurine-treated inflammatory bowel disease patients

(2011) Y. González-Lama et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Review article: defining remission in ulcerative colitis

(2011) S. P. L. Travis et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Review article: the benefits of pharmacogenetics for improving thiopurine therapy in inflammatory bowel disease

(2011) L. Chouchana et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Treatment of Hospitalized Adult Patients With Severe Ulcerative Colitis: Toronto Consensus Statements

(2011) Alain Bitton et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Corticosteroid use during pregnancy and risk of orofacial clefts

(2011) A. Hviid et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis

(2011) Jean Frédéric Colombel et al.   GASTROENTEROLOGY

Depth of remission may not predict outcome of UC over 2 years

(2011) D. C. Burger et al.   GUT

Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)

(2011) Simon P L Travis et al.   GUT

Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial

(2011) W. Reinisch et al.   GUT

Guidelines for the management of inflammatory bowel disease in adults

(2011) C. Mowat et al.   GUT

Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study

(2011) M. D. Kappelman et al.   GUT

Trough Levels and Antibodies to Infliximab May Not Predict Response to Intensification of Infliximab Therapy in Patients With Inflammatory Bowel Disease

(2011) Benjamin Pariente et al.   INFLAMMATORY BOWEL DISEASES

Double-blind, placebo-controlled trial of oral tacrolimus (FK506) in the management of hospitalized patients with steroid-refractory ulcerative colitis

(2011) Haruhiko Ogata et al.   INFLAMMATORY BOWEL DISEASES

The Prevalence and Efficacy of Ganciclovir on Steroid-refractory Ulcerative Colitis With Cytomegalovirus Infection

(2011) You Sun Kim et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

The effects of azathioprine on birth outcomes in women with inflammatory bowel disease (IBD)

(2011) Lisa Shim et al.   Journal of Crohns & Colitis

Association of Crohn’s Disease, Thiopurines, and Primary Epstein-Barr Virus Infection with Hemophagocytic Lymphohistiocytosis

(2011) Vincent F. Biank et al.   JOURNAL OF PEDIATRICS

Low-dose azathioprine or mercaptopurine in combination with allopurinol can bypass many adverse drug reactions in patients with inflammatory bowel disease

(2010) A. ANSARI et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

A Multicenter Experience With Infliximab for Ulcerative Colitis: Outcomes and Predictors of Response, Optimization, Colectomy and Hospitalization

(2010) Abderrahim Oussalah et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organisation: Pregnancy and Pediatrics

(2010) Uma Mahadevan et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Clinical Utility of Measuring Infliximab and Human Anti-Chimeric Antibody Concentrations in Patients With Inflammatory Bowel Disease

(2010) Waqqas Afif et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Delayed surgery for acute severe colitis is associated with increased risk of postoperative complications

(2010) J. Randall et al.   BRITISH JOURNAL OF SURGERY

Volume analysis of outcome following restorative proctocolectomy

(2010) E. M. Burns et al.   BRITISH JOURNAL OF SURGERY

Risk of Venous Thromboembolism With Inflammatory Bowel Disease

(2010) Tarek Saleh et al.   CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS

Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study

(2010) J. Coelho et al.   GUT

Usefulness of co-treatment with immunomodulators in patients with inflammatory bowel disease treated with scheduled infliximab maintenance therapy

(2010) H. Sokol et al.   GUT

Cytomegalovirus in inflammatory bowel disease: Pathogen or innocent bystander?

(2010) Garrett Lawlor et al.   INFLAMMATORY BOWEL DISEASES

Risk of malignant lymphoma in patients with inflammatory bowel diseases: A Dutch nationwide study

(2010) A. C.W. Vos et al.   INFLAMMATORY BOWEL DISEASES

Congenital abnormalities and other birth outcomes in children born to women with ulcerative colitis in Denmark and Sweden

(2010) Olof Stephansson et al.   INFLAMMATORY BOWEL DISEASES

Incidence of nodular regenerative hyperplasia in inflammatory bowel disease patients treated with azathioprine

(2010) Philippe Seksik et al.   INFLAMMATORY BOWEL DISEASES

Cyclosporine is Safe and Effective in Patients With Severe Ulcerative Colitis

(2010) Adam S. Cheifetz et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

European evidenced-based consensus on reproduction in inflammatory bowel disease

(2010) C. Janneke van der Woude et al.   Journal of Crohns & Colitis

A prospective evaluation of the impact of allopurinol in pediatric and adult IBD patients with preferential metabolism of 6-mercaptopurine to 6-methylmercaptopurine

(2010) Mark E. Gerich et al.   Journal of Crohns & Colitis

Factors affecting the efficacy of cyclosporin A therapy for refractory ulcerative colitis

(2010) Shigeki Bamba et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study

(2010) Matthew J Grainge et al.   LANCET

Predictive factors of poor response to intravenous cyclosporine in steroid-refractory ulcerative colitis

(2010) J. W. Huamán Ríos et al.   REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS

Mercaptopurine rescue after azathioprine-induced liver injury in inflammatory bowel disease

(2009) F. BERMEJO et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Ulcerative Colitis and Pregnancy Outcomes in an Asian Population

(2009) Herng-Ching Lin et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

The More the Better?

(2009) Paul J. Karanicolas et al.   ANNALS OF SURGERY

Early pregnancy azathioprine use and pregnancy outcomes

(2009) Brian J. Cleary et al.   BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY

Mesalamine Once Daily Is More Effective Than Twice Daily in Patients With Quiescent Ulcerative Colitis

(2009) Axel U. Dignass et al.   Clinical Gastroenterology and Hepatology

Risk of Lymphoma Associated With Combination Anti–Tumor Necrosis Factor and Immunomodulator Therapy for the Treatment of Crohn's Disease: A Meta-Analysis

(2009) Corey A. Siegel et al.   Clinical Gastroenterology and Hepatology

Infliximab Rescue Therapy after Cyclosporin Failure in Steroid-Refractory Ulcerative Colitis

(2009) Míriam Mañosa et al.   DIGESTION

Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis

(2009) C H Seow et al.   GUT

TNF-α is an important pathogenic factor contributing to reactivation of cytomegalovirus in inflamed mucosa of colon in patients with ulcerative colitis: Lesson from clinical experience

(2009) Hiroshi Nakase et al.   INFLAMMATORY BOWEL DISEASES

Long term efficacy and safety of allopurinol and azathioprine or 6-mercaptopurine in patients with inflammatory bowel disease

(2009) Yvette Leung et al.   Journal of Crohns & Colitis

IBD care in Europe: A comparative audit of the inpatient management of Crohn's disease and ulcerative colitis using the national UK IBD audit tool

(2009) Andrea Cassinotti et al.   Journal of Crohns & Colitis

Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study

(2009) Laurent Beaugerie et al.   LANCET

Hospitalized ulcerative colitis patients have an elevated risk of thromboembolic events

(2009) Jennifer Y Wang et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Long-term outcome of using allopurinol co-therapy as a strategy for overcoming thiopurine hepatotoxicity in treating inflammatory bowel disease

(2008) A. ANSARI et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Prospective evaluation of the pharmacogenetics of azathioprine in the treatment of inflammatory bowel disease

(2008) A. ANSARI et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Rising Prevalence of Venous Thromboembolism and Its Impact on Mortality Among Hospitalized Inflammatory Bowel Disease Patients

(2008) Geoffrey C. Nguyen et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Thiopurine-Induced Myelotoxicity in Patients With Inflammatory Bowel Disease: A Review

(2008) Javier P. Gisbert et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

A National Survey of the Prevalence and Impact of Clostridium difficile Infection Among Hospitalized Inflammatory Bowel Disease Patients

(2008) Geoffrey C. Nguyen et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Cyclosporine and Infliximab as Rescue Therapy for Each Other in Patients With Steroid-Refractory Ulcerative Colitis

(2008) Elana A. Maser et al.   Clinical Gastroenterology and Hepatology

The Management of Acute Severe Colitis: ACPGBI Position Statement

(2008) S. R. Brown et al.   Colorectal Disease

Clostridium difficile and inflammatory bowel disease

(2008) Mazen Issa et al.   INFLAMMATORY BOWEL DISEASES

Cytomegalovirus infection in ulcerative colitis: A prospective, comparative study on prevalence and diagnostic strategy

(2008) Eugeni Domènech et al.   INFLAMMATORY BOWEL DISEASES

Cytomegalovirus disappearance after treatment for refractory ulcerative colitis in 2 patients treated with infliximab and 1 patient with leukapheresis

(2008) Valeria Criscuoli et al.   INFLAMMATORY BOWEL DISEASES

Severe paediatric ulcerative colitis: incidence, outcomes and optimal timing for second-line therapy

(2007) D Turner et al.   GUT

Steroid-refractory ulcerative colitis: Predictive factors of response to cyclosporine and validation in an independent cohort

(2007) Montserrat Aceituno et al.   INFLAMMATORY BOWEL DISEASES